BNTX Competitors & Alternatives
Compare BioNTech SE with similar stocks in the same industry
Biotechnology
BNTX
Main Stock$88.45
Tradestie Score
50
Market Cap
$24.57B
Revenue Growth
-0.4%
Analyst Upside
+39.9%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
INSM
Insmed, Inc.
|
$103.86
|
$31.13B | - | 55 | Compare |
|
GMAB
Genmab A/S ADS
|
$23.88
|
$19.56B | 18.2 | 55 | Compare |
|
INCY
Incyte Genomics Inc
|
$97.98
|
$16.93B | 13.5 | 56 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$54.97
|
$15.70B | 28.4 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$15.07
|
$15.22B | - | 48 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$216.79
|
$12.36B | 24.6 | 57 | Compare |
|
EXEL
Exelixis Inc
|
$51.60
|
$11.09B | 16.1 | 60 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$28.70
|
$10.76B | - | 58 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$49.06
|
$10.74B | - | 50 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$54.66
|
$10.53B | 38.4 | 59 | Compare |
More BNTX Analysis
Data updated: Jun 03, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry